BGM Group Ltd. (BGM) stock
BGMNasdaqPharmaceutical PreparationsFiscal year ends September 30
$8.13+0.00 (0.00%)
Close on Nov 18, 2026Market cap $3.26BP/E –Yield –
BGM operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2025 it was -$12.58M. The highest annual figure on record is $6.18M in fiscal 2019.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$12.58M | – |
| FY2024 | Sep 30, 2024 | -$563.77K | – |
| FY2023 | Sep 30, 2023 | -$2.61M | -224.2% |
| FY2022 | Sep 30, 2022 | $2.10M | -12.0% |
| FY2021 | Sep 30, 2021 | $2.39M | -50.4% |
| FY2020 | Sep 30, 2020 | $4.81M | -22.1% |
| FY2019 | Sep 30, 2019 | $6.18M | +3.5% |
| FY2018 | Sep 30, 2018 | $5.97M | – |
See a number that looks wrong?